ClinicalTrials.gg
Sign In
Drug

Simlukafusp alfa clinical trials

Also written RO6874281.

studies test it
5
open now
0
in phase 3
0
first study started
2015

How each study uses simlukafusp alfa has had a first review. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

simlukafusp alfa
4

Development codes

RO6874281
5

Studies by the year they started

5 studies that test it; most in 2017 (2)

Studies that test simlukafusp alfa, by start year
YearStudies
20151
20172
20181
20191

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Melanoma
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Uterine Cervical Neoplasms
1

Who runs them

Industry 5 · Other 0

Hoffmann-La Roche (5)

Often tested with

Tested in the same studies.

Gemcitabine (2) · Albumin-Bound Paclitaxel (1) · Paclitaxel (1) · Cobimetinib (1) · PEGPH20 (1) · Motixafortide (1) · Selicrelumab (1) · Bevacizumab (1)

Studies

Open first, then newest update. How each study uses simlukafusp alfa has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 5

Tested with established drugs · 3 — they are given beside it
Tested in a combination · 2 — another drug in the study is under test too
Given beside what is tested · 1 — usual care or a partner of the new treatment

Codes

What other systems call simlukafusp alfa · ClinicalTrials.gg INT016571

  • UNII (FDA) FL08SGO9XASIMLUKAFUSP ALFAOne source FDA
  • NCI Thesaurus C129383Simlukafusp AlfaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion